Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.
about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisCannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.Simulation of Swanson's literature-based discovery: anandamide treatment inhibits growth of gastric cancer cells in vitro and in silico.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Silencing or amplification of endocannabinoid signaling in blastocysts via CB1 compromises trophoblast cell migrationHigh RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation.(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid: A stable isomer of 15(S)-HETE that retains key vasoconstrictive and antiproliferative activity.A Primary Cortical Input to Hippocampus Expresses a Pathway-Specific and Endocannabinoid-Dependent Form of Long-Term Potentiation.CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.The evolving role of the endocannabinoid system in gynaecological cancer.The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.Cannabinoid signaling in health and disease.Effect of N-arachidonoyl-l-serine on human cerebromicrovascular endothelium.18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.Loss of Cannabinoid CB 1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility.
P2860
Q26739831-9D878080-D23C-4D44-9CC1-969FB5BEBF5BQ26861766-6180C01F-1CBB-4E67-8203-C77B961A02C6Q33564023-2F324084-C4CD-4159-BF90-FF44D433D661Q33784314-1925BFA0-C5AB-4A55-A1C5-314569079773Q34766747-38A8482F-6CC2-40C7-B17B-1BB110B3800BQ36234840-EC70627C-4911-4640-B2E6-FF13D85409C1Q36524695-48DB49EA-9518-4D32-B25A-002355F8E997Q36971120-A80C269D-A33D-49C8-8C36-6D23E7025CDDQ37157298-EE48338C-016C-40F4-8A36-7470ABF1DFA4Q37289307-D84BBA75-B1F3-44AC-ADFB-E72C69C99D0FQ37723975-618783FB-A67C-47D8-A8B6-E9FD41AF372CQ38469671-8BC3400A-2229-4DFC-82DF-D4DD7CDF7CB3Q38763212-E22ACF27-B1D0-40D7-A14D-CC5ECBDC7ED3Q39163671-75B01588-DD63-44E4-BA07-DFD4E6C0668FQ41682627-1B72D431-0DCE-44EF-B71C-4619AA1719D4Q42564268-E7CDDC1D-45DE-4B0D-BFBC-0363175A4F1CQ46328841-7F164CD0-AFB9-4CFB-8502-678FC4D190A3
P2860
Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@ast
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@en
type
label
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@ast
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@en
prefLabel
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@ast
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@en
P2093
P2860
P921
P356
P1433
P1476
Cannabinoid receptor type 1 (C ...... y of prostate carcinoma cells.
@en
P2093
Adam W Pfeiffer
Alan T Tang
Ana Doris Gomez-Granados
Carol L Williams
Kasem Nithipatikom
William B Campbell
P2860
P356
10.1210/EN.2011-1144
P407
P577
2011-11-15T00:00:00Z